What’s The Deal With ME/CFS? For decades, a mystery syndrome has struck down up to 130 million people worldwide. Crushing fatigue, difficulty in thinking clearly, muscle aches, exhaustion after exercise that takes forever to go away, difficulty sleeping and more. This constellation of symptoms is referred to as Myalgic Encephalomyelitis (ME) or Chronic Fatigue Syndrome (CFS). […]

The post Journal Club: WASF3 disrupts mitochondrial respiration and may mediate exercise intolerance in myalgic encephalomyelitis/chronic fatigue syndrome appeared first on Medical News Bulletin.

A new study published in Proceedings of the National Academy of Science sheds some light on the role of a protein that may prevent ME/CFS patients from generating normal amounts of cellular energy.   A Medical Mystery ME/CFS has no known cause and is not well understood, even by medical professionals. The condition is characterized by […]

The post NIH Scientists discover biological basis for ME/CFS symptoms appeared first on Medical News Bulletin.

Parents of kids with type 2 diabetes will be relieved to know that two additional drugs have just received FDA approval for children over the age of 10. Newly Approved Diabetes Drugs The US Food and Drug Administration (FDA) announced in June 2023, the approval of Jardiance (empagliflozin) and Synjardy (empagliflozin and metformin hydrochloride) for type 2 […]

The post Jardiance and Synjardy Approved for Kids Aged Ten and Up appeared first on Medical News Bulletin.

Moorfields Eye Hospital London experts, led by Pearse Keane, have developed an Artificial Intelligence tool to provide a fast and reliable diagnosis for patients with eye-related diseases.  In recent years, there has been a rapid push to integrate artificial intelligence (AI) into healthcare systems. Artificial Intelligence (AI) serves to train a machine to make precise, swift, […]

The post Keeping an AI on Retinopathy appeared first on Medical News Bulletin.

Speed and precision are essential factors in cancer diagnosis and treatment. Melanoma patients benefit from many therapeutic options, but too much choice isn’t always a good thing. This means selecting the best course from a variety of therapies can be slow and difficult. Lucky for us, new medical tech in the form of microneedles may […]

The post No Sample Too Small for Harvard’s Microneedle Cancer Test appeared first on Medical News Bulletin.

Good news for men living with an enlarged prostate: clinicians have developed a novel way to treat Benign Prostate Hyperplasia (BPH) without sacrificing sexual function. On June 30, 2023, the FDA announced its approval of Optilume BPH for the treatment of an enlarged prostate. “The next-generation Optilume BPH Catheter System offers a safe and effective new, […]

The post Benign Prostate Hyperplasia: New Device Preserves Sexual Function appeared first on Medical News Bulletin.

The U.S. Food and Drug Administration (FDA) has expanded approval of QULIPTA® (atogepant) for use in preventative treatment of chronic migraine.1  In a press release from manufacturer AbbVie, Chief Medical Officer, Roopal Thakkar, explains, “Since September 2021, QULIPTA has helped people living with episodic migraine prevent migraine attacks, reducing the daily burden of migraine. Now, […]

The post FDA Approves Preventative Pill for Chronic Migraine appeared first on Medical News Bulletin.

If you frequently run a marathon or do heavy aerobic exercise, you may be pleasantly surprised. A study by a team from the Federal University of São Paulo in Brazil suggests that training not only improves balance and posture but could also slow the progression of Alzheimer’s disease.1 Alzheimer’s disease Alzheimer’s disease is one of […]

The post Push Back Against Alzheimer’s Disease appeared first on Medical News Bulletin.